A study listing describes three planned protocol components examining growth hormone administration in healthy men aged 25 to 50, with placebo use and extensive metabolic and laboratory assessments included in parts of the plan.
A ClinicalTrials.gov record describes a planned evaluation of EVER001 in selected proteinuric glomerular diseases, with primary membranous nephropathy named as the first target.
Read More
A registered study plans to compare ultrasound with micro-CT and LASCA while following healing after tooth extraction, bone grafting and before implant placement.
Read More
A ClinicalTrials.gov study record describes an intended evaluation of transverse tibial bone transport for chronic ischemic and diabetic lower-extremity ulcers, focusing on safety, clinical performance, wound healing and limb preservation.
Read More
A registered randomized clinical trial is designed to compare three resin composite layering approaches for Class IV anterior tooth fractures, with shade matching, clinical performance and patient satisfaction planned over 12 months.
Read More